Affymetrix lands ParAllele acquisition
DEALS |
|||
WHO |
WITH |
WHAT |
SCOOP |
Affymetrix |
ParAllele BioScience |
$120M buyout |
When used with Affymetrix GeneChip technology, ParAllele's proprietary assay effectively gives researchers a powerful "molecular microscope" for examining the entire genome. |
NBTY |
Solgar Vitamin and Herb |
$115M buyout |
Solgar manufactures and distributes nutritional supplements, including multivitamins, minerals, botanicals and specialty formulas. |
Qiagen |
artus Gesellschaft |
$39.2M buyout |
Artus is a leader in PCR-based molecular diagnostic tests for pathogenenic, genotyping and pharmacogenomic testing. |
Chromos Molecular Systems |
Targeted Molecules |
Acquisition, stock and notes |
Targeted Molecules has been focused on the research and development of two antibody product candidates for the treatment of multiple sclerosis and acute thrombosis. |